News
Dexcom Study Shows CGM Benefits for Diabetes Patients Not Using Insulin
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
